tiprankstipranks
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market
ONCO
Oncopeptides AB
RESEARCH TOOLSreports
Want to see SE:ONCO full AI Analyst Report?

Oncopeptides AB (ONCO) Income Statement

9 Followers

Oncopeptides AB Income Statement

Last quarter (Q2 2025), Oncopeptides AB's total revenue was kr19.18M, an increase of 135.23% from the same quarter last year. In Q2, Oncopeptides AB's net income was kr-62.85M. See Oncopeptides AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 71.12Mkr 31.65Mkr 35.22Mkr 8.36Mkr 118.30M
Gross Profit
kr 68.67Mkr 28.98Mkr 36.30Mkr 8.35Mkr 65.17M
Operating Expenses
kr 297.49Mkr 312.48Mkr 289.75Mkr 357.70Mkr 1.49B
Depreciation and Amortization
kr 0.00kr 9.75Mkr 11.04Mkr 17.18Mkr 21.36M
EBITDA
kr -228.82Mkr -261.81Mkr -231.62Mkr -319.62Mkr -1.40B
Operating Income
kr -228.82Mkr -283.50Mkr -253.45Mkr -349.35Mkr -1.42B
Other Income/Expenses
kr -19.34Mkr -711.00Kkr 5.00Mkr 11.67Mkr -455.00K
Pretax Income
kr -248.17Mkr -284.21Mkr -248.45Mkr -337.68Mkr -1.42B
Net Income
kr -249.59Mkr -284.61Mkr -249.11Mkr -337.95Mkr -1.43B
Per Share Metrics
Basic EPS
kr -1.10kr -1.71kr -1.96kr -4.11kr -19.00
Diluted EPS
kr -1.10kr -1.71kr -1.96kr -4.11kr -19.00
Weighted Average Shares Outstanding
 226.90M 166.44M 126.84M 82.32M 75.29M
Weighted Average Shares Outstanding (Diluted)
 226.90M 166.44M 126.84M 82.32M 75.29M
Currency in SEK

Oncopeptides AB Earnings and Revenue History